I agree. Look at the impact one freakin analyst had on this stock. Sorry...Robin you may in fact be a great CEO, however, you are perceived as a "snake oil salesperson." Show everyone you are wrong or give up your position. You owe it to the stockholders. You hurting this stock more than anything else. Maybe I should have said " smoothie salesperson."
I think he really has an issue with the CEO. If we had a respected CEO this stock would be over $10.00. Granted there are some valid questions about the phase II study, however, I think the CEO is weighting this stock down more than anything.